发明名称 |
ANTIBODIES AGAINST APRIL AS BIOMARKERS FOR EARLY PROGNOSIS OF LYMPHOMA PATIENTS |
摘要 |
<p>The invention relates to antibodies directed against APRIL (A Proliferation Inducing TNF Ligand, also known as TALL-2) , in particular the monoclonal antibody Aprily-2, hybridoma cells producing monoclonal antibody Aprily-2, and the use of a combination of an antibody against membrane-anchored APRIL and Aprily-2 in the diagnosis of B cell lymphoma resistance to treatment and the prognosis of clinical development of Diffuse Large B-CeII (DLBCL) lymphoma from high risk patients (> 60 years and International Prognostic Index > 2) . An amino acid sequence GTGGPSQNGEGYP called Stalk, useful in the preparation of antibodies, is described.</p> |
申请公布号 |
CA2623530(C) |
申请公布日期 |
2015.02.03 |
申请号 |
CA20062623530 |
申请日期 |
2006.09.22 |
申请人 |
APOTECH CORPORATION;UNIVERSITY OF GENEVA |
发明人 |
HUARD, BERTRAND;FRENCH, LARS;DONZE, OLIVIER;MURONE, MAXIMILIEN |
分类号 |
C07K16/24;C07K7/08;C12N5/16;G01N33/53 |
主分类号 |
C07K16/24 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|